SVETLANA KONSTANTINOVNA KOTOVSKAYA

Dr. SVETLANA KONSTANTINOVNA KOTOVSKAYA


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in Chemistry
Verified
Journal Article
Open access
PDF file
NMNataliya N. Mochulskaya
Nataliya N. Mochulskaya
SKSVETLANA KONSTANTINOVNA KOTOVSKAYA
SVETLANA KONSTANTINOVNA KOTOVSKAYA
Ilya ButorinIlya Butorin
Ilya Butorin
MVMikhail V. Varaksin
Mikhail V. Varaksin
VCValery N. Charushin
Valery N. Charushin
VZVladimir V. Zarubaev
Vladimir V. Zarubaev
A series of 2,4-disubstituted pyrrolo[2,1-f][1,2,4]triazines containing both aryl and thienyl substituents were synthesized by exploiting the 1,3-cycloaddition reaction of N(1)-ethyl-1,2,4-triazinium tetrafluoroborates with dimethyl acetylenedicarboxylate. The antiviral activity of the synthesized compounds against influenza virus strain A/Puerto Rico/8/34 (H1N1) was studied in experiments on Madin-Darby canine kidney (MDCK) cell culture. Among the pyrrolo[2,1-f][1,2,4]triazine derivatives, compounds with low toxicity and high antiviral activity were identified. Dimethyl 4-(4-methoxyphenyl)-7-methyl-2-p-tolylpyrrolo[2,1-f][1,2,4]triazine-5,6-dicarboxylate was found to demonstrate the best antiviral activity (IC50 4 µg/mL and selectivity index 188). Based on the results of in vitro tests and molecular docking studies performed, a plausible mechanism of action for these compounds was suggested to involve inhibition of neuraminidase.